The catecholamine neurotransmitter dopamine (DA) modulates multiple behavioral processes in man including learning,arousal, reward, cognition and motor control, faculties disrupted in neuropsychiatric and neurodegenerative disorders such as bipolar disorder, schizophrenia, attention deficit hyperactivity disorder (ADHD) and Parkinson's Disease. Overall DA signaling is regulated by modulation of the neurotransmitter's biosynthesis, packaging, release, metabolism and receptor activation, but the temporal and spatial duration of DA action is controlled by the presynaptic dopamine transporter (DAT). DATs clear synaptic DA via Na-dependent uptake, returning the catecholamine to the presynaptic terminal where it can be repackaged and re-released. In C. elegans, DAT-1 supports DA reuptake, is expressed solely within DA neurons, preferentially transports DA, and is blocked by psychoactive compounds and substrates such as cocaine and amphetamine as well as the tricyclic antidepressant imipramine. Our previous studies show that DAT-1 is an important modulator of endogenous DA levels because
dat-1 worms exhibit a DA-dependent locomotory phenotype termed Swimming Induced Paralysis (SWIP). Briefly, whereas wild-type worms will swim continuously for 15-20 min when placed in a small volume of water,
dat-1 worms will paralyze within 2-3 min. SWIP is mediated by an increase in extrasynaptic DA, as
dat-1 animals are rescued by reserpine-induced depletion of DA from synaptic vesicles, by loss of DA biosynthesis (
cat-2) or with loss of the postsynaptic receptor DOP-3. Although reverse genetic approaches have been successfully implemented to study DATs in worm and rodent models, unbiased forward genetic approaches are necessary to expand our knowledge of presynaptic factors regulating DA signaling. In the current study, we capitalized on the SWIP phenotype to pursue a forward genetic screen that identifies hyperdopaminergic strains. To date, we have screened ~ 10,000 haploid genomes and we have isolated 12 stable lines that maintain the SWIP phenotype after outcrossing. In addition, we have thoroughly characterized two of these lines, swip2 and swip3, demonstrating that they harbor loss-of-function mutations in DAT-1 coding sequences, providing vital proof-of-concept evidence that our screen targets genes involved in the presynaptic regulation of DA signaling. Supported by NIH award DA027739 to R.D.B. and S.L.H.